Journal
IMMUNOLOGY
Volume 138, Issue 2, Pages 116-123Publisher
WILEY-BLACKWELL
DOI: 10.1111/imm.12016
Keywords
antibody-dependent cellular cytotoxicity; Env; HIV; slow-progressor; Vpu
Categories
Funding
- NHMRC [510448, 455350]
- ARC award [LP0991498]
- Australian Centre for HIV and Hepatitis Virology Research
- The Royal Australasian College of Physicians
- The Ramaciotti Foundation
- National Institutes of Health [R21AI081541]
- Australian Research Council [LP0991498] Funding Source: Australian Research Council
Ask authors/readers for more resources
Antibody-dependent cellular cytotoxicity (ADCC) is potentially an effective adaptive immune response to HIV infection. However, little is understood about the role of ADCC in controlling chronic infection in the small number of long-term slow-progressors (LTSP) who maintain a relatively normal immunological state for prolonged periods of time. We analysed HIV-specific ADCC responses in sera from 139 HIV+ subjects not on antiretroviral therapy. Sixty-five subjects were LTSP, who maintained a CD4 T-cell count > 500/mu l for over 8 years after infection without antiretroviral therapy and 74 were non-LTSP individuals. The ADCC responses were measured using an natural killer cell activation assay to overlapping HIV peptides that allowed us to map ADCC epitopes. We found that although the magnitude of ADCC responses in the LTSP cohort were not higher and did not correlate with CD4 T-cell depletion rates, the LTSP cohort had significantly broader ADCC responses compared with the non-LTSP cohort. Specifically, regulatory/accessory HIV-1 proteins were targeted more frequently by LTSP. Indeed, three particular ADCC epitopes within the Vpu protein of HIV were recognized only by LTSP individuals. Our study provides evidence that broader ADCC responses may play a role in long-term control of HIV progression and suggests novel vaccine targets.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available